Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -239.4% | -56.0% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.8 | 0.8 |
Pr/Book | 1.5 |
Latest | F'cast | |
---|---|---|
Revenue | 138.0% | 131.5% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 0.72 | (9.07) | (7.55)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 10.39 | (1.89) | (1.89)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.52 | (19.91) | (10.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 5.50 | (49.43) | (21.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 13.09 | (32.38) | (5.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 30.29 | (16.98) | (2.38)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 67.08 | (8.75) | (0.51)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 55.74 | (7.44) | (1.16)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Business Update | 21-Nov-2024 | 07:00 | RNS |
Q3 Trading Update | 29-Oct-2024 | 07:00 | RNS |
Results from Phase 3 paediatric study | 25-Sep-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 2.95p |
Change Today | 0.28p |
% Change | 10.28 % |
52 Week High | 7.65p |
52 Week Low | 1.23p |
Volume | 40,674,235 |
Shares Issued | 782.06m |
Market Cap | £23.07m |
Beta | 1.88 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:30 | 50,000 @ 2.95p |
16:25 | 500,000 @ 3.23p |
16:24 | 250,000 @ 2.90p |
16:17 | 33,878 @ 2.94p |
16:16 | 15,000 @ 2.94p |
You are here: research